Non-24-hour sleep-wake disorder
GPTKB entity
Statements (35)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Sleep disorder
circadian rhythm sleep disorder |
| gptkbp:affects |
blind individuals
quality of life circadian rhythm sighted individuals |
| gptkbp:alsoKnownAs |
gptkb:N24SWD
gptkb:Non-24 |
| gptkbp:cause |
cognitive impairment
occupational impairment social impairment dysfunction of the circadian clock |
| gptkbp:characterizedBy |
sleep-wake cycle that is not aligned with the 24-hour day
|
| gptkbp:duration |
chronic
|
| gptkbp:firstDescribed |
1971
|
| gptkbp:frequency |
common in totally blind population
rare in sighted population |
| gptkbp:hasTreatmentApproval |
tasimelteon approved by FDA for Non-24 in blind individuals
|
| https://www.w3.org/2000/01/rdf-schema#label |
Non-24-hour sleep-wake disorder
|
| gptkbp:ICD-10_code |
G47.24
|
| gptkbp:prevalence |
common in totally blind individuals
|
| gptkbp:relatedTo |
gptkb:Irregular_sleep–wake_rhythm_disorder
gptkb:Delayed_sleep_phase_disorder |
| gptkbp:riskFactor |
visual impairment
total blindness |
| gptkbp:symptom |
insomnia
excessive daytime sleepiness difficulty waking up progressive delay in sleep onset progressive delay in wake time |
| gptkbp:treatment |
gptkb:tasimelteon
gptkb:melatonin light therapy |
| gptkbp:bfsParent |
gptkb:Circadian_rhythm_disorders
|
| gptkbp:bfsLayer |
6
|